Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug–drug interaction study of CNT-01 with digoxin and rosuvastatin
jRCT2031220678Phase 1Completed
- Sponsor
- TOA EIYO
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of tricaprin in idiopathic triglyceride deposit cardiomyovasculopathy (I-TGCV) (2 arms), sponsored by TOA EIYO. Primary endpoint: Pharmacokinetics. Started Mar 2023; status: completed.
02
Drugs
tricaprin
03
Conditions
idiopathic triglyceride deposit cardiomyovasculopathy (I-TGCV)
Beyond the preview
Go deeper on jRCT2031220678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220678.